# Effect of Exercise, Endocannabinoids and Ketones on Cerebral Metabolism in a Cognitive Disorders Population

> **NCT04322461** · NA · COMPLETED · sponsor: **Université de Sherbrooke** · enrollment: 14 (actual)

## Conditions studied

- Parkinson Disease
- Alzheimer Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Betaquik MCT supplement

## Key facts

- **NCT ID:** NCT04322461
- **Lead sponsor:** Université de Sherbrooke
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-01
- **Primary completion:** 2024-05-27
- **Final completion:** 2024-05-27
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2025-06-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04322461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04322461, "Effect of Exercise, Endocannabinoids and Ketones on Cerebral Metabolism in a Cognitive Disorders Population". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04322461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*